Partnership between Oklo and Atomic Alchemy for isotope production

Oklo Inc. and Atomic Alchemy launch a partnership to increase the production of industrial and medical isotopes, essential in various sectors including cancer treatment.

Share:

Partenariat Oklo Atomic Alchemy Isotope

Comprehensive energy news coverage, updated nonstop

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access • Archives included • Professional invoice

OTHER ACCESS OPTIONS

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

FREE ACCOUNT

3 articles offered per month

FREE

*Prices are excluding VAT, which may vary depending on your location or professional status

Since 2021: 35,000 articles • 150+ analyses per week

Against a backdrop of worldwide shortages of medical and industrial isotopes, Oklo Inc. and Atomic Alchemy announce strategic partnership to increase production of essential isotopes. This partnership leverages Oklo’s capabilities in fast fission technology and nuclear fuel recycling with Atomic Alchemy’s expertise in isotope production. Together, they plan to build and operate fast reactors that will not only be a source ofclean energy production, but also a platform for the production of vital isotopes for medical diagnostics, cancer treatment and industrial applications.

Technology and innovation at the heart of the partnership

Oklo’s fast reactors and advanced fuel recycling processes form the technological basis of this partnership. These technologies will enable the production of a wide range of isotopes, including those currently in critical short supply, such as those used in radioisotope thermoelectric generators and advanced cancer therapies. Oklo uses a reactor technology that optimizes the use of nuclear fuel and minimizes waste, while increasing the efficiency of isotope production.

Economic and security implications

This partnership is strategic not only from a technological point of view, but also from an economic and security one. By increasing domestic isotope production, the USA could reduce its dependence on foreign sources, often located in geopolitically unstable areas. This initiative is all the more relevant given that global demand for medical isotopes is rising steadily, fuelled by advances in cancer diagnosis and treatment technologies.

Challenges and prospects

The partnership between Oklo and Atomic Alchemy is not without its challenges. The complexity of isotope production requires considerable investment in research and development, as well as strict regulatory safeguards to ensure the safety and efficacy of the isotopes produced. However, the heads of both companies, Jacob DeWitte of Oklo and Thomas Eiden of Atomic Alchemy, are confident in their ability to overcome these obstacles thanks to their combined expertise and the support of their strategic and financial partners.
The partnership between Oklo and Atomic Alchemy is a bold step forward in securing the supply of isotopes vital to many sectors. It represents not only a technological breakthrough, but also a strategic initiative that could redefine energy production and public health standards in the United States.

Belarus commits major public investment to add a third reactor at the Ostrovets plant and initiates studies for a second nuclear site to support national energy demand.
Framatome’s accident-tolerant fuel prototype has completed a second 24-month cycle in a commercial nuclear reactor in the United States, paving the way for a third phase of industrial testing.
The Wylfa site in Wales will host three Rolls-Royce small modular reactors from 2026, marking a strategic investment in the UK’s nuclear expansion.
EDF confirmed that the Flamanville EPR has reached a major milestone, while planning a nearly year-long shutdown in 2026 for extensive regulatory inspections and key component replacement.
EDF is opening access to its long-term nuclear supply contracts to companies consuming more than 7 GWh per year, an adjustment driven by the gradual end of the Arenh mechanism.
South Korean authorities have approved the continued operation of the Kori 2 reactor for an additional eight years, marking a key milestone in the national nuclear strategy.
A public-private consortium is developing a 5 MW thermal microreactor designed to operate without refuelling for ten years, marking a strategic step in Brazil's nuclear innovation efforts.
EDF has announced that the Flamanville EPR reactor is now operating at 80% of its capacity. The target of reaching full output by the end of autumn remains confirmed by the utility.
The accelerated approval of the Aurora facility’s nuclear safety plan marks a strategic milestone in rebuilding a domestic nuclear fuel production line in the United States.
The Industrikraft consortium will invest SEK400mn ($42.2mn) to become a shareholder in Videberg Kraft, marking a new phase in Sweden’s nuclear project led by Vattenfall on the Värö Peninsula.
MVM Group has signed an agreement with Westinghouse to secure VVER-440 fuel supplies from 2028, reducing its reliance on Russia and strengthening nuclear cooperation between Budapest and Washington.
The delivery of nuclear fuel by Russian subsidiary TVEL to the Da Lat research reactor marks a key step in strengthening the nuclear commercial partnership between Moscow and Hanoi.
US supplier X-energy has formalised a graphite supply contract with Japan's Toyo Tanso for the construction of its first four small modular reactors, in partnership with Dow and backed by the US Department of Energy.
US-based Enveniam has signed an agreement with LIS Technologies Inc. to oversee the design and construction of a new laser-based uranium enrichment facility on American soil.
Faced with shorter approval timelines, several European nuclear firms, including Newcleo, Orano and Urenco, are considering relocating key industrial investments to the United States.
A consortium led by Swedish giants such as ABB, SSAB and Volvo will invest SEK400mn to support the development of small modular nuclear reactors through a strategic partnership with Vattenfall.
Fusion Fuel Cycles has begun work on its UNITY-2 facility, a unique test bench designed to validate the full tritium fuel cycle under fusion conditions, marking a key step toward fusion energy.
Framatome will produce TRISO fuel at Romans-sur-Isère as part of a pilot project for advanced nuclear reactors, in partnership with actors such as Blue Capsule Technology.
Sweden’s parliament has approved a major reform authorising uranium extraction, opening the door to a reassessment of the economic potential of mining projects containing this strategic mineral.
South Africa's regulator has authorised Koeberg Unit 2 to operate until 2045 following maintenance work and a long-term safety assessment.

All the latest energy news, all the time

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access - Archives included - Pro invoice

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

*Prices shown are exclusive of VAT, which may vary according to your location or professional status.

Since 2021: 30,000 articles - +150 analyses/week.